Market Overview:
The global felbinac market is expected to register a CAGR of xx% during the forecast period 2018-2030. The market growth can be attributed to the increasing demand for felbinac in various applications such as felbinac gel, felbinac tincture, and felbinac patch. Additionally, the growing awareness about the benefits of using Felbinac is also propelling the growth of this market. However, stringent regulatory norms related to drug approvals are restraining the growth of this market. Based on type, 98% purity type segment is expected to hold a dominant position in the global Felbinac market during 2018-2030. This can be attributed to its high purity and better performance as compared to other types available in the market.
 Industry Outlook.svg)
Product Definition:
A nonsteroidal antiinflammatory drug (NSAID) used to treat pain, inflammation, and fever. It works by blocking the production of a certain chemical in the body that causes pain and inflammation.
98% Purity Type:
98% Purity Type is a form of hydroxypropyl methyl cellulose. It has high purity and is manufactured using advanced technology to remove impurities. 98% Purity Type has applications in pharmaceuticals, food additives, cosmetics & personal care products and chemical industries owing to its high purity level as compared to other forms of Hydroxypropyl Methyl Cellulose (HPMC).
97% Purity Type:
97% purity type is a form of hydroxypropyl methyl cellulose that has been processed to remove impurities. It is a white crystalline solid and is soluble in water, ethanol, and ethyl ether. 97% purity type can be used as an additive for felbinac (CAS 5728-52-9) manufacturing process by mixing it with the right amount of carrier material such as ethanol or water depending on the end product required.
Application Insights:
Felbinac gel was the most dominant application segment in terms of revenue share, which accounted for over 65.0% of the global market volume in 2017. The product is used as an antifungal and anti-inflammatory agent owing to its high concentration of benzoyl peroxide, a well-established compound with excellent penetration through the skin. It can be used on mild to moderately severe eczema cases and helps reduce inflammation at a cellular level without causing any harm to healthy skin cells.
The felbinac tincture segment is expected register the fastest growth rate during forecast years due to increasing demand for products that are more convenient than taking pills or injections every day.
Regional Analysis:
North America dominated the global market in 2017. The presence of a large number of manufacturers coupled with high R&D expenditure by companies is expected to drive the demand for felbinac in this region. In addition, increasing incidence of skin disorders and diseases such as eczema and psoriasis has led to an increase in demand for natural products that can provide effective treatment, which is further anticipated to propel growth over the forecast period.
Asia Pacific is expected to witness fastest growth over the forecast period owing to rising disposable income leading consumers towards medical tourism especially from India, China, Japan & South Korea. This trend will lead towards increased spending on healthcare thereby fueling industry expansion over next eight years.
Europe was valued at USD X million in 2017.
Growth Factors:
- Increasing demand from pharmaceutical and cosmetic industries
- Growing awareness about the benefits of felbinac among consumers
- Rising investment in research and development for novel applications of felbinac
- Proliferation of online retail platforms that offer discounts on bulk purchases
- Growing popularity of natural ingredients in personal care products
Scope Of The Report
Report Attributes
Report Details
Report Title
Felbinac (CAS 5728-52-9) Market Research Report
By Type
98% Purity Type, 97% Purity Type, Others
By Application
Felbinac Gel, Felbinac Tincture, Felbinac Patch, Others
By Companies
BLD Pharm, Anward, Aba Chem Scene, TripleBond, LGC Standard, Aurum Pharmatech, FREDA, Hua Luo, Meryer
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
234
Number of Tables & Figures
164
Customization Available
Yes, the report can be customized as per your need.
Global Felbinac (CAS 5728-52-9) Market Report Segments:
The global Felbinac (CAS 5728-52-9) market is segmented on the basis of:
Types
98% Purity Type, 97% Purity Type, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Felbinac Gel, Felbinac Tincture, Felbinac Patch, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- BLD Pharm
- Anward
- Aba Chem Scene
- TripleBond
- LGC Standard
- Aurum Pharmatech
- FREDA
- Hua Luo
- Meryer
 Market Overview.svg)
Highlights of The Felbinac (CAS 5728-52-9) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 98% Purity Type
- 97% Purity Type
- Others
- By Application:
- Felbinac Gel
- Felbinac Tincture
- Felbinac Patch
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Felbinac (CAS 5728-52-9) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Felbinac is a drug used to treat pain. It is a type of opioid.
Some of the major companies in the felbinac (cas 5728-52-9) market are BLD Pharm, Anward, Aba Chem Scene, TripleBond, LGC Standard, Aurum Pharmatech, FREDA, Hua Luo, Meryer.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Felbinac (CAS 5728-52-9) Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Felbinac (CAS 5728-52-9) Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Felbinac (CAS 5728-52-9) Market - Supply Chain
4.5. Global Felbinac (CAS 5728-52-9) Market Forecast
4.5.1. Felbinac (CAS 5728-52-9) Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Felbinac (CAS 5728-52-9) Market Size (000 Units) and Y-o-Y Growth
4.5.3. Felbinac (CAS 5728-52-9) Market Absolute $ Opportunity
5. Global Felbinac (CAS 5728-52-9) Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Felbinac (CAS 5728-52-9) Market Size and Volume Forecast by Type
5.3.1. 98% Purity Type
5.3.2. 97% Purity Type
5.3.3. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Felbinac (CAS 5728-52-9) Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Felbinac (CAS 5728-52-9) Market Size and Volume Forecast by Application
6.3.1. Felbinac Gel
6.3.2. Felbinac Tincture
6.3.3. Felbinac Patch
6.3.4. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Felbinac (CAS 5728-52-9) Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Felbinac (CAS 5728-52-9) Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Felbinac (CAS 5728-52-9) Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Felbinac (CAS 5728-52-9) Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Felbinac (CAS 5728-52-9) Demand Share Forecast, 2019-2026
9. North America Felbinac (CAS 5728-52-9) Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Felbinac (CAS 5728-52-9) Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Felbinac (CAS 5728-52-9) Market Size and Volume Forecast by Application
9.4.1. Felbinac Gel
9.4.2. Felbinac Tincture
9.4.3. Felbinac Patch
9.4.4. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Felbinac (CAS 5728-52-9) Market Size and Volume Forecast by Type
9.7.1. 98% Purity Type
9.7.2. 97% Purity Type
9.7.3. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Felbinac (CAS 5728-52-9) Demand Share Forecast, 2019-2026
10. Latin America Felbinac (CAS 5728-52-9) Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Felbinac (CAS 5728-52-9) Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Felbinac (CAS 5728-52-9) Market Size and Volume Forecast by Application
10.4.1. Felbinac Gel
10.4.2. Felbinac Tincture
10.4.3. Felbinac Patch
10.4.4. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Felbinac (CAS 5728-52-9) Market Size and Volume Forecast by Type
10.7.1. 98% Purity Type
10.7.2. 97% Purity Type
10.7.3. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Felbinac (CAS 5728-52-9) Demand Share Forecast, 2019-2026
11. Europe Felbinac (CAS 5728-52-9) Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Felbinac (CAS 5728-52-9) Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Felbinac (CAS 5728-52-9) Market Size and Volume Forecast by Application
11.4.1. Felbinac Gel
11.4.2. Felbinac Tincture
11.4.3. Felbinac Patch
11.4.4. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Felbinac (CAS 5728-52-9) Market Size and Volume Forecast by Type
11.7.1. 98% Purity Type
11.7.2. 97% Purity Type
11.7.3. Others
11.8.Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Felbinac (CAS 5728-52-9) Demand Share, 2019-2026
12. Asia Pacific Felbinac (CAS 5728-52-9) Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Felbinac (CAS 5728-52-9) Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Felbinac (CAS 5728-52-9) Market Size and Volume Forecast by Application
12.4.1. Felbinac Gel
12.4.2. Felbinac Tincture
12.4.3. Felbinac Patch
12.4.4. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Felbinac (CAS 5728-52-9) Market Size and Volume Forecast by Type
12.7.1. 98% Purity Type
12.7.2. 97% Purity Type
12.7.3. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Felbinac (CAS 5728-52-9) Demand Share, 2019-2026
13. Middle East & Africa Felbinac (CAS 5728-52-9) Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Felbinac (CAS 5728-52-9) Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Felbinac (CAS 5728-52-9) Market Size and Volume Forecast by Application
13.4.1. Felbinac Gel
13.4.2. Felbinac Tincture
13.4.3. Felbinac Patch
13.4.4. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Felbinac (CAS 5728-52-9) Market Size and Volume Forecast by Type
13.7.1. 98% Purity Type
13.7.2. 97% Purity Type
13.7.3. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Felbinac (CAS 5728-52-9) Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Felbinac (CAS 5728-52-9) Market: Market Share Analysis
14.2. Felbinac (CAS 5728-52-9) Distributors and Customers
14.3. Felbinac (CAS 5728-52-9) Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. BLD Pharm
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Anward
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Aba Chem Scene
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. TripleBond
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. LGC Standard
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Aurum Pharmatech
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. FREDA
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Hua Luo
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Meryer
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
